enGene Therapeutics (ENGN) Q4 2024 Earnings

Dec 19Confirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-0.46
-0.39
-0.33
-0.26

Details

Expected EPS
-0.395714
Actual EPS
-0.35
Surprise EPS
0.05
Surprise Percent
+11.55%

Description

⁨enGene Therapeutics⁩ (⁦ENGN⁩) has reported earnings of ⁦-0.35⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts